FDA: Treatment with angiotensin receptor blockers for high blood pressure does not increase risk of cancer

Posted by Food and Drug Administration--Press Releases on Thursday Jun 2, 2011 Under News

The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using the medications.

Be Sociable, Share!

Comments are closed.